Andrew Berens
Stock Analyst at Leerink Partners
(4.14)
Main Sectors:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
CELC Celcuity | Maintains: Outperform | 28 60 | 57.19 | 4.91% | 2 | Jul 28, 2025 | |
COGT Cogent Biosciences | Maintains: Outperform | 16 18 | 12.75 | 41.18% | 5 | Jul 7, 2025 | |
NUVL Nuvalent | Maintains: Outperform | 125 140 | 80.91 | 73.03% | 2 | Jun 24, 2025 | |
ARVN Arvinas | Downgrades: Market Perform | 10 9 | 8.02 | 12.22% | 6 | Jun 2, 2025 | |
CMPX Compass Therapeutics | Upgrades: Outperform | 4 6 | 3.54 | 69.49% | 3 | Apr 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 9 1 | n/a | n/a | 5 | Mar 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 880 762 | 566.08 | 34.61% | 1 | Jan 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 33 | 2.51 | 1214.74% | 1 | Dec 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 10 25 | 15.82 | 58.03% | 10 | Nov 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 74 96 | 116.36 | -17.5% | 1 | Oct 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 60 56 | 36.1 | 55.12% | 11 | Sep 27, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 5 3 | n/a | n/a | 5 | Aug 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Market Perform | 50 97 | 129.46 | -25.07% | 24 | May 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 78 | 86.04 | -9.34% | 12 | Dec 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 78 58 | 58.7 | -1.19% | 7 | Nov 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 13 10 | 9.1 | 0% | 2 | May 16, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 35 48 | 68.44 | -29.87% | 5 | Apr 17, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 30 | 25.59 | 17.23% | 11 | Feb 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 162 141 | 228.74 | -38.36% | 19 | Feb 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 236 300 | 184.71 | 62.42% | 11 | Jan 20, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 37 28 | 9.22 | 203.69% | 3 | Dec 13, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 78 79 | 81.18 | -2.69% | 12 | Nov 14, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 42 27 | 1.51 | 1688.08% | 7 | Nov 10, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 4 | Oct 24, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 40 30 | n/a | n/a | 4 | Aug 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 69 | n/a | n/a | 4 | Aug 9, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 101 76 | n/a | n/a | 6 | Jun 13, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 25 23 | 20.01 | 14.94% | 5 | May 27, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 36 25 | 6.6 | 278.79% | 3 | May 13, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 40 | 6.5 | 515.38% | 1 | Nov 23, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 28 | 4.07 | 587.96% | 1 | Nov 1, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 67 | 2.69 | 2390.71% | 1 | Oct 14, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Perform | 20 | 4.94 | 304.86% | 1 | Oct 14, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 25 | 6.43 | 288.8% | 1 | Sep 20, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 12 16 | 1.47 | 988.44% | 5 | May 7, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 4 3 | n/a | n/a | 6 | Nov 6, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Overweight | 2000 | 1.42 | 140745.07% | 2 | Sep 7, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 156 146 | n/a | n/a | 3 | Mar 1, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 102 18 | n/a | n/a | 2 | Sep 22, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 75 50 | 19 | 163.16% | 5 | Sep 22, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 16 8 | 12.88 | -37.89% | 7 | Jul 14, 2017 |